Search
According to the most recent research report issued by Sinolink Securities, the policy trajectory has become clear following the press conference and a series of symposiums conducted by the National Healthcare Security Administration. Moving forward, policies will be geared towards aiding enterprises in their efforts to "curb excessive internal rivalry," venture into overseas markets, and engage in differentiated innovation. These measures are poised to propel the medical device industry towards high-caliber growth. The incentive for companies to invest in innovative research and development (R&D) will be bolstered, with leading firms in specialized sectors projected to see a stabilization in their profit margins. The profit potential for groundbreaking products is set to widen, and the domestic market's growth rate is expected to experience a swift resurgence.
-
C114 Communication Network -
Communication Home
